AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on: April 28,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on:April 28,2024

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Updated on: January 30,2024

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Updated on:January 30,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on: April 01,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on:April 01,2024

Right-sided colon cancer patients have poorer survival than those with left-sided disease

by American College of SurgeonsKiller T cells surround a cancer cell. Credit: NIHORLANDO (July 23, 2018): Patients with colorectal cancer tumors on the right side may have poorer five-year surviv

Updated on: May 07,2024

Right-sided colon cancer patients have poorer survival than those with left-sided disease

by American College of SurgeonsKiller T cells surround a cancer cell. Credit: NIHORLANDO (July 23, 2018): Patients with colorectal cancer tumors on the right side may have poorer five-year surviv

Updated on:May 07,2024

A new way to help the immune system fight back against cancer

by Kaine Korzekwa,University of Wisconsin-MadisonImmune cells, which look like small, clear circles, next to a small red sphere of neuroblastoma (cancer) cells. When researchers add an anti-neur

Updated on: May 07,2024

A new way to help the immune system fight back against cancer

by Kaine Korzekwa,University of Wisconsin-MadisonImmune cells, which look like small, clear circles, next to a small red sphere of neuroblastoma (cancer) cells. When researchers add an anti-neur

Updated on:May 07,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on: March 21,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on:March 21,2024

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Updated on: January 02,2024

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Updated on:January 02,2024

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Updated on: November 09,2024

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Updated on:November 09,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on: May 23,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on:May 23,2024

Immune system plays vital role in longer multiple myeloma remission, new study shows

byUniversity of Miami Leonard M. Miller School of MedicineStudy design and treatment outcomes. a Immune profiling was performed on blood and bone marrow collected from 23 patients with multiple

Updated on: January 12,2024

Immune system plays vital role in longer multiple myeloma remission, new study shows

byUniversity of Miami Leonard M. Miller School of MedicineStudy design and treatment outcomes. a Immune profiling was performed on blood and bone marrow collected from 23 patients with multiple

Updated on:January 12,2024

Tracing the footprints of a tumor—genomic 'scars' allow cancer profiling

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesHap1 Cells stained for different DNA damages (yellow = antibody against phosphorilated ATM; red = antibody against 53B

Updated on: April 01,2024

Tracing the footprints of a tumor—genomic 'scars' allow cancer profiling

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesHap1 Cells stained for different DNA damages (yellow = antibody against phosphorilated ATM; red = antibody against 53B

Updated on:April 01,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on: September 30,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on:September 30,2024